Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
How does Spotify Wrapped calculate your listening age? What your number says about you. - 2German finance minister seeks better market access in China talks
- 315 Preposterous Cosplay Ensembles That Will Blow You Away
- 4Los Angeles County sees significant uptick in norovirus cases, officials say
- 5IDF kills four terrorists equipped with weapons, surveillance gear near Gaza's Yellow Line
- Watch interstellar comet 3I/ATLAS speed away from the sun in free telescope livestream on Nov. 16
- Ukraine Now Using Drone Boats To Attack Russian Riverine Targets
- How did I get my own unique set of fingerprints?
- Believe Should Unwind? Look at These Scaled down Games
- Which '80s Film Actually Holds Up Today?
- The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding
- AstraZeneca to invest $2 billion as part of US manufacturing push
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Avoid Large Crowds In Bali & Swim At This Peaceful Waterfall With A Gorgeous, Natural Pool
